Telecom & Wireless Global On demand · 24-48h

Global Wireless Fetal Monitoring Device Market Strategic Research Report

Global Wireless Fetal Monitoring Device Market Strategic Res…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Wireless Fetal Monitoring Device Market
$9312025
9.6%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: External Fetal Monitoring Devices, Internal Fetal Monitoring Devices

By Application: Hospitals, Clinics, Birthing Centers

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: GE Healthcare, Philips, ArjoHuntleigh, Analogic Corporation, Neoventa Medical AB, Spacelabs Healthcare, Natus Medical Incorporated, MedGyn Products, Inc., Dixion Vertrieb medizinischer Gerate GmbH, Bionet Co., Ltd., Shenzhen Unicare Electronic Co., Ltd., Koninklijke Philips N.V., Sunray Medical Apparatus Co., Ltd., OBMedical Company Limited, EDAN Instruments, Inc., Shenzhen Luckcome Technology Inc., ShenZhen OSEN Technology Co., Ltd., Mediana Co., Ltd., General Meditech Inc., Shenzhen Comen Medical Instruments Co., Ltd., Mindchild Medical, Babyscripts, Owlet

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 150 pages
Market size 2025
$931
Million USD
Forecast CAGR
9.6%
2025-2032
Forecast 2032
$1768.6
Projected
Regions
5
Asia Pacific · Latin America · MEA · Europe · North America

Overview

Scope of the Report

The global Wireless Fetal Monitoring Device market size is predicted to grow from US$ 931 million in 2025 to US$ 1,746 million in 2032; it is expected to grow at a CAGR of 9.6% from 2026 to 2032.

A wireless fetal monitor is a medical device based on wireless transmission technology. It uses sensors (such as Doppler ultrasound probes or electrode patches) to collect the fetal heart rate (FHR) and the uterine contraction signal (UC) of pregnant women in real time, and uses Bluetooth, Wi-Fi or the Internet of Things (IoT) to transmit data to smart terminals (such as mobile phones, tablets or central monitoring systems) for remote monitoring and analysis. Its core functions include: real-time data tracking (such as dynamic display of fetal heart rate curve), abnormal warning (AI algorithm automatically identifies risks such as deceleration), and multi-scenario adaptation (hospital clinical monitoring and home use), aiming to improve perinatal safety and reduce medical resource pressure.

The wireless fetal monitor market is in a rapid growth stage, with the main driving factors including: technology upgrades (such as Bluetooth low power consumption, AI-assisted analysis), the outbreak of home use scenarios (the epidemic has driven the demand for home monitoring), and policy support (countries have increased investment in perinatal care). The market dynamics show two major trends: one is portability and intelligence, such as wearable devices integrating fetal heart rate monitoring functions; the other is the integration of telemedicine, which enables real-time data sharing between doctors and patients through cloud platforms. For example, the uBaby series of Libang Instruments supports remote monitoring via mobile phone APP, while the AI ​​algorithm automatically identifies abnormal fetal heart rate, reduces the risk of misdiagnosis, and promotes the market to penetrate deeply from hospitals to home scenarios.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Wireless Fetal Monitoring Device market?

What factors are driving Wireless Fetal Monitoring Device market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Wireless Fetal Monitoring Device market opportunities vary by end market size?

How does Wireless Fetal Monitoring Device break out by Type, by Application?

This report presents a comprehensive overview of the global Wireless Fetal Monitoring Device market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • External Fetal Monitoring Devices
  • Internal Fetal Monitoring Devices

Segment by Application

  • Hospitals
  • Clinics
  • Birthing Centers

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Wireless Fetal Monitoring Device market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Hospitals, Clinics, Birthing Centers evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Wireless Fetal Monitoring Device Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 9.6%
Regional growth momentum
Market share by segment
Key metrics
Base value
$931
2025
Forecast
$1768.6
2032
CAGR
9.6%
2025–2032
Regions
5
global
Key companies
GE HealthcarePhilipsArjoHuntleighAnalogic CorporationNeoventa Medical ABSpacelabs HealthcareNatus Medical IncorporatedMedGyn Products, Inc.
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
External Fetal Monitoring DevicesInternal Fetal Monitoring Devices
By Application
HospitalsClinicsBirthing Centers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 External Fetal Monitoring Devices
  • 3.1.3 Internal Fetal Monitoring Devices
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Hospitals
  • 4.1.3 Clinics
  • 4.1.4 Birthing Centers
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 GE Healthcare
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Philips
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 ArjoHuntleigh
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Analogic Corporation
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Neoventa Medical AB
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Spacelabs Healthcare
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Natus Medical Incorporated
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 MedGyn Products, Inc.
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Dixion Vertrieb medizinischer Gerate GmbH
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Bionet Co., Ltd.
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Shenzhen Unicare Electronic Co., Ltd.
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Koninklijke Philips N.V.
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Sunray Medical Apparatus Co., Ltd.
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 OBMedical Company Limited
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 EDAN Instruments, Inc.
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Shenzhen Luckcome Technology Inc.
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 ShenZhen OSEN Technology Co.,Ltd.
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Mediana Co., Ltd.
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 General Meditech Inc.
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
  • 8.20 Shenzhen Comen Medical Instruments Co., Ltd.
  • 8.20.1 Company Overview
  • 8.20.2 Key Products & Segments
  • 8.20.3 Financial Performance (2023–2025)
  • 8.20.4 Business Strategy
  • 8.20.5 SWOT Analysis
  • 8.20.6 Strategic Implications (2026–2032)
  • 8.21 Mindchild Medical
  • 8.21.1 Company Overview
  • 8.21.2 Key Products & Segments
  • 8.21.3 Financial Performance (2023–2025)
  • 8.21.4 Business Strategy
  • 8.21.5 SWOT Analysis
  • 8.21.6 Strategic Implications (2026–2032)
  • 8.22 Babyscripts
  • 8.22.1 Company Overview
  • 8.22.2 Key Products & Segments
  • 8.22.3 Financial Performance (2023–2025)
  • 8.22.4 Business Strategy
  • 8.22.5 SWOT Analysis
  • 8.22.6 Strategic Implications (2026–2032)
  • 8.23 Owlet
  • 8.23.1 Company Overview
  • 8.23.2 Key Products & Segments
  • 8.23.3 Financial Performance (2023–2025)
  • 8.23.4 Business Strategy
  • 8.23.5 SWOT Analysis
  • 8.23.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

How big is the global Wireless Fetal Monitoring Device market?
The global Wireless Fetal Monitoring Device market is estimated at US$ 931 million in 2025 (base year) and is projected to reach US$ 1.75 billion by 2032.
How fast is the Wireless Fetal Monitoring Device market expected to grow?
The market is expected to grow at a CAGR of 9.6% from 2026 to 2032, expanding from US$ 931 million in 2025 to US$ 1.75 billion in 2032, roughly 1.9 times its base-year value.
What does the Wireless Fetal Monitoring Device market cover?
A wireless fetal monitor is a medical device based on wireless transmission technology. It uses sensors (such as Doppler ultrasound probes or electrode patches) to collect the fetal heart rate (FHR) and the uterine contraction signal (UC) of pregnant women in real time, and uses Bluetooth, Wi-Fi or the Internet of Things (IoT) to transmit data to smart terminals (such as mobile phones, tablets or central monitoring systems) for remote monitoring and analysis.
How is the Wireless Fetal Monitoring Device market segmented by type?
By type, the market is segmented into External Fetal Monitoring Devices and Internal Fetal Monitoring Devices.
What are the key applications of Wireless Fetal Monitoring Device?
Key applications covered include Hospitals, Clinics and Birthing Centers.
Which companies are profiled in the Wireless Fetal Monitoring Device market report?
Key players profiled include GE Healthcare, Philips, ArjoHuntleigh, Analogic Corporation, Neoventa Medical AB, Spacelabs Healthcare, Natus Medical Incorporated and MedGyn Products, among 23 companies covered in total.
What geographies does the Wireless Fetal Monitoring Device market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Wireless Fetal Monitoring Device?
The wireless fetal monitor market is in a rapid growth stage, with the main driving factors including: technology upgrades (such as Bluetooth low power consumption, AI-assisted analysis), the outbreak of home use scenarios (the epidemic has driven the demand for home monitoring), and policy support (countries have increased investment in perinatal care).
Who should buy the Wireless Fetal Monitoring Device market report?
The report is intended for manufacturers and solution providers, distributors and end users in Hospitals, Clinics and Birthing Centers, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Wireless Fetal Monitoring Device market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.